According to a BSE notice, the equity shares of Piramal Pharma Limited shall be listed and admitted to dealings on the exchange in the list of T Group of Securities on October 19. The shares would be listed at a fully paid face value of ₹10 each. Piramal Pharma was demerged from Piramal Enterprises to simplify the company's corporate structure.